Altimmune Inc (ALT) Stock Price, Quote, News & History

ALTNASDAQ
$2.97
At close: Sep 30, 5:00 PM EST
$2.96
-0.0097-0.33%
After Hours: 7:52 PM EST

Altimmune (ALT) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-76.51M
Investing Cash Flow (TTM)
-453.61M
Financing Cash Flow (TTM)
410.02M
Free Cash Flow (TTM)
-76.56M
Capital Expenditure (TTM)
-54.00K
Net Change in Cash (TTM)
-120.10M

Analyst Trends and Forecast

1
May
1
Jun
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$287.46M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
12109.96
PB Ratio (TTM)
1.22
Earnings Yield % (TTM)
-25.59%
Earnings Yield % (FWD)
-21.21%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.44

Company Debt

Total Debt
$34.74M
LT Debt
$34.74M
LT Debt Issuance (TTM)
$20.40M
LT Debt Repayment (TTM)
-
Total Cash
$63.01M
Debt to Equity
0.08
Issuance of Debt (TTM)
$20.40M
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 4.20M
Day Range
- - -
52 Wk Range
2.56 - 6.44
Market Cap
$575.83M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
26.64%
Days to Cover
15.38

About

Sector
Health Care
Industry
Biotechnology
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanc...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Altimmune (ALT) stock?

A

You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Altimmune (ALT) competitors?

Q

What is the forecast, or price target, for Altimmune (ALT) stock?

A

Altimmune has a consensus price target of $17.00.

Q

What is the current price for Altimmune (ALT)?

A

The stock price for Altimmune (NASDAQ: ALT) is $2.9603 last updated September 29, 2026 at 7:52 PM EDT.

Q

Does Altimmune (ALT) pay a dividend?

A

There are no upcoming dividends for Altimmune.

Q

When is Altimmune (NASDAQ:ALT) reporting earnings?

A

Altimmune does not have any upcoming earnings scheduled.

Q

Is Altimmune (ALT) going to split?

A

There is no upcoming split for Altimmune.

Q

What sector and industry does Altimmune (ALT) operate in?

A

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.